Catalyst Wire Dossier Catalyst Wire Dossier

Tapentadol Extended Release (JNS024ER)

tapentadol · Janssen Pharmaceutical K.K.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Tapentadol Extended Release (JNS024ER), covering 2013-04-17 to 2013-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Study of Tapentadol Extended-Release (JNS024ER) ) in Japanese Participants With Chronic Pain Due to Diabetic Neuropathic Pain or Postherpetic Neuralgia [Phase 2]

See pricing